MAPK7 and cancer: Genetic perturbation of ERK5 has suggested that modulationof ERK5 activity may have therapeutic potential in cancer chemotherapy.This Miniperspective examines the evidence for ERK5 as a drug targetin cancer, the structure of ERK5, and the evolution of structurallydistinct chemotypes of ERK5 kinase domain inhibitors.